Emcure Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts

Emcure Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Jan-Mar 2026 Oct-Dec 2025 Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Emcure Pharmaceuticals Ltd.
17 Nov 2025
1540.60
1.24%
pdf
AI Summary
logo
Emcure Pharmaceuticals Ltd.
13 Aug 2025
1540.60
1.24%
AI Summary
pdf
logo
Emcure Pharmaceuticals Ltd.
07 Aug 2025
1540.60
1.24%
pdf
logo
Emcure Pharmaceuticals Ltd.
07 Aug 2025
1540.60
1.24%
Emcure Pharmaceuticals Results Earnings Call for Q1FY26
Conference Call with Emcure Pharmaceuticals Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
AI Summary
logo
Emcure Pharmaceuticals Ltd.
28 May 2025
1540.60
1.24%
AI Summary
pdf
logo
Emcure Pharmaceuticals Ltd.
22 May 2025
1540.60
1.24%
pdf
logo
Emcure Pharmaceuticals Ltd.
22 May 2025
1540.60
1.24%
Emcure Pharmaceuticals Results Earnings Call for Q4FY25 & Full Year
Conference Call with Emcure Pharmaceuticals Ltd. Management and Analysts on Q4FY25 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
AI Summary
logo
Emcure Pharmaceuticals Ltd.
11 Feb 2025, 06:36PM
1540.60
1.24%
AI Summary
pdf
logo
Emcure Pharmaceuticals Ltd.
06 Feb 2025
1540.60
1.24%
pdf
logo
Emcure Pharmaceuticals Ltd.
06 Feb 2025
1540.60
1.24%
Emcure Pharmaceuticals Results Earnings Call for Q3FY25
Conference Call with Emcure Pharmaceuticals Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.
video
 

Earnings Calls Podcast on